Oxford’s cancer vaccine/immunotherapy combo to head for human trials
Oxford scientists have demonstrated a cancer vaccine and immunotherapy combo in mice. The vaccine boosted levels of tumor-hunting immune cells, while the immunotherapy made them more effective killers. Human trials are due to start within months. Source of Article